The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Cognitive Deficits in Adolescents With Schizophrenia Undergoing Antipsychotic Treatment

Published Online:https://doi.org/10.1176/ajp.156.3.497a

To the Editor: John T. Kenny, M.D., and colleagues (1) reported that adolescent schizophrenic patients showed neuropsychological deficits. Although they indicate that all patients were treated with antipsychotic drugs, they did not specify dosage. Thus, cognitive impairment might be linked to the antipsychotics’ side effects such as sedation, attention and motivation impairments, and mild extrapyramidal effects manifesting themselves as a slowing down in the completion of some testing tasks. These possible side effects cast doubt on the interpretation of the neuropsychological test results. It would seem premature to advance the pessimistic assertion that there are cognitive deficits in adolescents with schizophrenia.

References

1. Kenny JT, Friedman L, Findling RL, Swales TP, Strauss ME, Jesberger JA, Schulz SC: Cognitive impairment in adolescents with schizophrenia. Am J Psychiatry 1997; 154:1613–1615LinkGoogle Scholar